Issue of Equity

Eco Animal Health Group plc ("Eco" or the "Company") The Company announces that on 7 November 2008, 899,635 new ordinary shares of 5p each were issued to shareholders who elected to receive new shares instead of cash for the Final dividend in respect of the year ended 31 March 2008 and who held Ordinary shares on the record date of 26 September 2008. The new shares are expected to be admitted to trading on 10 November 2008. Following this scrip dividend, the Company has 46,402,407 ordinary shares in issue and the following directors' shareholdings have increased. Number of Shareholding Percent shares held post scrip shareholding prior to post scrip scrip Peter 10,110,376 10,500,000 22.23% Lawrence & family Executive Chairman Kevin 7,563 7,776 0.02% Stockdale Finance Director Enquires: Eco Animal Health Group plc Peter Lawrence, Executive Chairman 020 8336 6190 Cenkos Securities plc Liz Bowman 020 7397 8926 (Nominated Adviser) ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products. Our products for these global growth markets promote well-being in animals. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.
UK 100

Latest directors dealings